8+ years of preclinical and translational research across oncology, metabolic disorders, and infectious disease — from Bangladesh to South Dakota to Texas.
Research & Professional Experience
Leading translational research in infectious disease, focusing on anti-bacterial synergy, bacterial resistance, and therapeutic regimen development.
Conducting HTP drug screening campaigns using clinical libraries and human/mouse cell lines for target prioritization and lead discovery.
Executing PK/PD and host immune response studies, integrating in vivo pharmacology with immuno assay readouts.
Collaborating cross-functionally with discovery biology, pharmacology, and omics teams to support go/no-go decisions in early discovery pipelines.
Abstract accepted at AACR Annual Meeting 2026; 2 abstracts submitted to ASM Microbe 2026.
Designed and characterized 5 preclinical mouse/rat models: diet-induced obesity (DIO), orthotopic TNBC, AOM/DSS colorectal cancer, and MNU-induced breast cancer.
Executed in vivo metabolic phenotyping: GTT, OGTT, IPGTT, ITT, indirect calorimetry (CLAMS), MRI body composition, and plasma insulin ELISA.
Performed IHC (19 biomarkers), IF (8 biomarkers), and multiplex immunostaining to study TME remodeling and pharmacodynamic response.
Led digital pathology and spatial image analysis using Visiopharm and ImageJ for reproducible biomarker quantification.
Supported HTS campaigns and target validation assays; performed Western blot, PCR, ELISA, and SPR.
Developed 3T3-L1 / PY230 co-culture models to study obesity-associated hypoxia-induced inflammation in tumor.
Managed lab operations as Facility Manager and Radioisotope Laboratory Manager (2020–2024).
Contributed to preclinical research projects in pharmaceutical sciences as a contract researcher prior to full appointment.
Supported in vivo study execution, tissue collection, and laboratory protocols across active research projects.
Conducted microbiological research supporting gut microbiota and colon carcinogenesis studies.
Contributed to research on fermented diet interventions and inflammation-associated colorectal cancer, published in Molecular Carcinogenesis.
Presented research at SDSU Allied Health Sciences Annual Research Symposium — awarded Best Research Poster Presenter.
Conducted independent wet-lab research in pharmacology and biochemistry.
Co-authored research on Trihydroxybenzoic Acid as an antioxidant plant metabolite inhibiting cancer cell growth in vitro (Free Radicals and Antioxidants).
Gained hands-on pharmaceutical industry experience at a global top-tier pharma company.
Exposure to industrial drug manufacturing, quality control, and regulated laboratory practices.